Longitudinal model –based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer
ConclusionOur modeling and simulation framework can be applied to support indirect comparison, dose selection, and go/no-go decision-making for new agents targeting CRPC.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Databases & Libraries | Docetaxel | Drugs & Pharmacology | Prostate Cancer | Study | Taxotere